analyst
NB
NASDAQ · NBIX
Neurocrine Biosciences, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$156.22
Down-$0.35 (-0.22%)
Updated Sep 13, 2026, 4:16 PM
SID Score
6.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 15.39B
- P/E ratio
- 35.94
- Dividend yield
- 0.00%
- 52-week range
- $122.14 – $186.12
- Volume
- 890.88K
- Avg. volume
- 958.25K
Price performance
NBIX price history
1M range · 19 trading sessions · Daily adjusted prices
NBIX closed at $156.22 after 19 trading sessions, up 1.12% for the selected period.
- Last close
- $156.22
- Period change
- +1.12%
- Period low
- $152.57
- Period high
- $158.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $157.195 | $159.67 | $156.12 | $156.22 | 890.88K |
| Sep 10, 2026 | $154.38 | $159.94 | $152.04 | $156.57 | 895.2K |
| Sep 9, 2026 | $154.61 | $155.55 | $152.38 | $155.14 | 1.05M |
| Sep 8, 2026 | $153.99 | $156.82 | $151.77 | $155.13 | 820.81K |
| Sep 4, 2026 | $158.24 | $159.7999 | $154.83 | $155.64 | 933.57K |
| Sep 3, 2026 | $159.93 | $159.93 | $156.76 | $158.35 | 758.26K |
| Sep 2, 2026 | $157.39 | $160.425 | $155.09 | $157.79 | 1.04M |
| Sep 1, 2026 | $154.31 | $157.03 | $153.7001 | $156.76 | 878.44K |
| Aug 31, 2026 | $153.11 | $155.00 | $151.77 | $154.03 | 1.74M |
| Aug 28, 2026 | $155.92 | $156.57 | $153.08 | $154.06 | 812.99K |
| Aug 27, 2026 | $155.28 | $156.75 | $154.61 | $155.92 | 730.29K |
| Aug 26, 2026 | $153.21 | $159.40 | $152.02 | $156.59 | 1.12M |
| Aug 25, 2026 | $153.84 | $156.1299 | $152.005 | $153.37 | 1.04M |
| Aug 24, 2026 | $152.57 | $154.56 | $151.77 | $153.04 | 1.21M |
| Aug 21, 2026 | $153.13 | $155.265 | $152.51 | $152.57 | 1.23M |
| Aug 20, 2026 | $154.99 | $155.81 | $152.50 | $152.93 | 870.66K |
| Aug 19, 2026 | $156.555 | $156.555 | $154.34 | $155.54 | 1.16M |
| Aug 18, 2026 | $155.92 | $156.24 | $153.4625 | $154.23 | 1.04M |
| Aug 17, 2026 | $151.62 | $154.81 | $150.69 | $154.49 | 1.17M |
Latest NBIX news
The latest Smart Investors Daily articles mentioning NBIX.
Stock researchCompany · Financials
Loading stock research…